Browse Title Index
| Issue | Title | |
| Vol 6, No 4 (2015) | Appendix 9. A writ from the Minister of Finance to the Standing Committee of the Council of Ministers, concerning public consultation in regard to the Council of Ministers’ Draft Regulation on the merger between the Institutes | Abstract PDF (Polish) |
| Krzysztof Warzocha | ||
| Vol 1, No 2 (2010) | Approved, new antithrombotic agents: rivaroxaban and dabigatran | Abstract PDF (Polish) |
| Witold Z. Tomkowski | ||
| Vol 8, No 2 (2017) | Assessment of nutritional status in patients with myeloid and lymphoid neoplasms, using the PG-SGA score | Abstract PDF (Polish) HTML (Polish) |
| Agata Lewandowska, Alicja Elżbieta Woźniak, Katarzyna Bożena Budziszewska, Joanna Góra-Tybor, Krzysztof Jamroziak, Ewa Lech-Marańda, Krzysztof Warzocha | ||
| Vol 10, Supp. B (2019) | Azacitidine treatment of patient with acute myeloid leukemia secondary to myelofibrosis | Abstract PDF (Polish) |
| Agnieszka Pluta, Dorota Jesionek-Kupnicka, Ewa Wawrzyniak, Agnieszka Wierzbowska | ||
| Vol 2, No 3 (2011) | Bendamustine in therapy of lymphoid malignancies | Abstract PDF (Polish) |
| Iwona Hus, Anna Korycka-Wołowiec, Justyna Dzietczenia, Piotr Boguradzki, Tomasz Wróbel | ||
| Vol 10, No 1 (2019) | Benefit/risk profile of idelalisib treatment in patients with chronic lymphocytic leukemia and non-Hodgkin lymphoma | Abstract PDF |
| Bartosz Puła, Agnieszka Giza, Monika Długosz-Danecka, Justyna Rybka, Edyta Subocz, Anna Waszczuk-Gajda, Magdalena Piotrowska, Magdalena Rej, Krzysztof Jamroziak, Wojciech Jurczak | ||
| Vol 14 (2023): Continuous Publishing | Bispecific antibodies in the treatment of follicular lymphoma | Abstract PDF |
| Aleksandra Bogucka-Fedorczuk, Tomasz Wróbel | ||
| Vol 12, No 1 (2021) | Blastic plasmacytoid dendritic cell neoplasm (BPDCN) — diagnostic and therapeutic challenge | Abstract PDF |
| Jarosław Wajs, Małgorzata Lewandowska, Przemysław Kluge, Lucyna Drążek, Dorota Jesionek-Kupnicka | ||
| Vol 7, No 4 (2016) | Blinatumomab — a novel drug in patients with relapsed/refractory acute lymphoblastic leukemia | Abstract PDF (Polish) |
| Joanna Sawczuk-Chabin, Anna Ejduk, Ewa Lech-Marańda | ||
| Vol 6, Supp. A (2015) | Bortezomib in the elderly patient with plasma cell myeloma who relapsed after auto-HSCT | Abstract PDF (Polish) |
| Monika Joks, Mieczysław Komarnicki | ||
| Vol 6, Supp. A (2015) | Bortezomib in the first-line treatment of patients with plasma cell myeloma and renal failure | Abstract PDF (Polish) |
| Agnieszka Kopacz | ||
| Vol 6, Supp. A (2015) | Bortezomib in the second-line treatment of plasma cell myeloma when thalidomide treatment fails | Abstract PDF (Polish) |
| Agata Malenda | ||
| Vol 6, Supp. A (2015) | Bortezomib in the treatment of plasma cell myeloma with t(4;14) | Abstract PDF (Polish) |
| Agnieszka Janus | ||
| Vol 6, Supp. A (2015) | Bortezomib plus melphalan and prednisone for initial treatment of plasma cell myeloma in transplant-ineligible patient with renal failure | Abstract PDF (Polish) |
| Anna Waszczuk-Gajda, Grzegorz Charliński, Dor ota Zduńczyk, Kamila Skwierawska, Małgorzata Paszkowska-Kowalewska, Beata Gierej, Bogna Ziarkiewicz-Wróblewska, Jadwiga Dwilewicz-Trojaczek | ||
| Vol 13, No 2 (2022) | Burkitt-like lymphoma with 11q aberration mimicking appendicitis in a young man — a diagnostic and therapeutic challenge | Abstract PDF |
| Ryszard Swoboda, Karolina Gajda, Roman Lamch, Sebastian Giebel | ||
| Vol 6, No 3 (2015) | CD4+CD8+ lymphocytosis and pleural and pericardiac effusions in a patient with chronic myelogenous leukemia in chronic phase treated with dasatinib due to imatinib failure | Abstract PDF (Polish) HTML (Polish) |
| Krzysztof Lewandowski, Agata Lehman-Kopydłowska, Michał Gniot, Anna Czyż, Błażej Ratajczak, Mieczysław Komarnicki | ||
| Vol 2, No 4 (2011) | Cerebral venous and sinus thrombosis complicated by heparin-induced thrombocytopenia | Abstract PDF (Polish) |
| Anna Sikorska, Małgorzata Tomaszewska, Beata Baran, Izabella Klimowicz-Młodzik, Krystyna Maślanka, Jerzy Windyga | ||
| Vol 5, No 2 (2014) | Characteristics and prognostic significance of T regulatory lymphocytes in lymphoid malignancies | Abstract PDF (Polish) HTML (Polish) |
| Magdalena Głowala-Kosińska, Sebastian Giebel | ||
| Vol 7, No 1 (2016) | Chelation therapy in patients with iron overload due to frequent blood transfusions | Abstract PDF (Polish) HTML (Polish) |
| Jadwiga Dwilewicz-Trojaczek, Anna Waszczuk-Gajda | ||
| Vol 5, No 4 (2014) | Chemotherapy and radiotherapy-induced nausea and vomiting — guidelines of prophylaxis in patients treated for myeloid and lymphoid neoplasms | Abstract PDF (Polish) HTML (Polish) |
| Ewa Kalinka-Warzocha, Krzysztof Warzocha | ||
| Vol 2, No 4 (2011) | Chronic eosinophilic leukemia with erythroblastic proliferation and the translocation (8;9)(p22;p24) with PCM1-JAK2 fusion gene — a new clinical, pathological and genetic entity with potential treatment target? | Abstract PDF (Polish) |
| Monika Prochorec-Sobieszek, Barbara Nasiłowska-Adamska, Katarzyna Borg, Izabella Kopeć, Kinga Kos-Zakrzewska, Grażyna Nowak, Przemysław Juszczyński, Krzysztof Warzocha | ||
| Vol 4, No 2 (2013) | Chronic lymphocytic leukemia „slow-go”: what does it mean and how to treat it? | Abstract PDF (Polish) HTML (Polish) |
| Dariusz Stanisław Wołowiec, Anna Korycka-Wołowiec | ||
| Vol 3, No 3 (2012) | Chronic myeloid leukemia as the second myeloproliferative neoplasm evolving after primary myelofibrosis | Abstract PDF (Polish) |
| Bożena Katarzyna Budziszewska, Monika Prochorec-Sobieszek, Katarzyna Borg, Iwona Solarska, Ewa Lech-Marańda, Krzysztof Warzocha | ||
| Vol 1, No 2 (2010) | Chronic thromboembolic pulmonary hypertension: epidemiology, pathogenesis and natural history | Abstract PDF (Polish) |
| Maria Wieteska, Andrzej Biederman, Adam Torbicki | ||
| Vol 4, No 1 (2013) | Classifi cation and diagnosis of von Willebrand disease | Abstract PDF (Polish) |
| Ksenia Bykowska | ||
| 51 - 75 of 543 Items | << < 1 2 3 4 5 6 7 8 9 10 > >> | |
By VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
phone:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl
